Price (delayed)
$17.8
Market cap
$1.11B
P/E Ratio
9.37
Dividend/share
N/A
EPS
$1.9
Enterprise value
$1.23B
Avid Bioservices is a dedicated contract development and manufacturing organization (CDMO) focused on development and CGMP manufacturing of biopharmaceutical drug substances derived from mammalian cell culture. The company provides a
There are no recent dividends present for CDMO.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.